PTC-AADC Shows Benefits for Patients with AADC Deficiency, Data Shows

Recently, biopharmaceutical company PTC Therapeutics, Inc. performed a five-year data analysis to evaluate the continued safety, efficacy, and tolerability of PTC-AADC. The company developed this novel gene therapy to improve…

Continue Reading PTC-AADC Shows Benefits for Patients with AADC Deficiency, Data Shows